Dillaha Larry (0001360463)

Mailing Address 6195 SHILOH ROAD ALPHARETTA GA 30005 Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.) Issuer Filings Transaction Date Type of Owner REPROS THERAPEUTICS INC. 0000897075 2017-02-01 officer: Interim President and CEO Insys Therapeutics, Inc. 0001516479 2013-05-02 officer: Chief Medical Officer FIRST HORIZON PHARMACEUTICAL CORP Current Name:SCIELE PHARMA, INC. 0001106773 2006-04-26 officer: EVP & Chief Medical Officer

Items 1 - 34

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition	Transaction Date	Deemed Execution Date	Issuer	Form	Transaction Type	Direct or Indirect Ownership	Number of Securities Transacted	Number of Securities Owned	Line Number	Issuer CIK	Security Name
D	2014-03-05		Insys Therapeutics, Inc.	4	D-Return	--D	18750.0000	81250.0000	14	0001516479	Stock Option (right to buy)
D	2014-03-05		Insys Therapeutics, Inc.	4	S-Sale	--D	17863.0000	19079.0000	12	0001516479	Common Stock
D	2014-03-05		Insys Therapeutics, Inc.	4	S-Sale	--D	2304.0000	36942.0000	11	0001516479	Common Stock
D	2014-03-05		Insys Therapeutics, Inc.	4	S-Sale	--D	3811.0000	39246.0000	10	0001516479	Common Stock
D	2014-03-05		Insys Therapeutics, Inc.	4	S-Sale	--D	5717.0000	43057.0000	9	0001516479	Common Stock
D	2014-03-05		Insys Therapeutics, Inc.	4	S-Sale	--D	4680.0000	48774.0000	8	0001516479	Common Stock
D	2014-03-05		Insys Therapeutics, Inc.	4	S-Sale	--D	624.0000	53454.0000	7	0001516479	Common Stock
D	2014-03-05		Insys Therapeutics, Inc.	4	S-Sale	--D	653.0000	54078.0000	6	0001516479	Common Stock
D	2014-03-05		Insys Therapeutics, Inc.	4	S-Sale	--D	537.0000	54731.0000	5	0001516479	Common Stock
D	2014-03-05		Insys Therapeutics, Inc.	4	S-Sale	--D	97789.0000	55268.0000	4	0001516479	Common Stock
A	2014-03-05		Insys Therapeutics, Inc.	4	M-Exempt	--D	112126.0000	153057.0000	3	0001516479	Common Stock
A	2014-03-05		Insys Therapeutics, Inc.	4	M-Exempt	--D	19056.0000	40931.0000	2	0001516479	Common Stock
A	2014-03-05		Insys Therapeutics, Inc.	4	M-Exempt	--D	18750.0000	21875.0000	1	0001516479	Common Stock
D	2014-03-05		Insys Therapeutics, Inc.	4	S-Sale	--D	15954.0000	3125.0000	13	0001516479	Common Stock
D	2014-03-05		Insys Therapeutics, Inc.	4	D-Return	--D	19056.0000	29944.0000	15	0001516479	Stock Option (right to buy)
D	2014-03-05		Insys Therapeutics, Inc.	4	D-Return	--D	112126.0000	0.0000	16	0001516479	Stock Option (right to buy)
A	2013-05-14		Insys Therapeutics, Inc.	4	A-Award	--D	100000.0000	100000.0000	1	0001516479	Stock Option (right to buy)
D	2008-08-11		SCIELE PHARMA, INC.	4	S-Sale	--D	875.0000	74511.0000	1	0001106773	Common
D	2008-04-25		SCIELE PHARMA, INC.	4	S-Sale	--D	350.0000	75386.0000	1	0001106773	Common
D	2008-02-20		SCIELE PHARMA, INC.	4	S-Sale	--D	875.0000	75736.0000	1	0001106773	Common
D	2008-01-23		SCIELE PHARMA, INC.	4	S-Sale	--D	438.0000	76611.0000	1	0001106773	Common
D	2007-12-07		SCIELE PHARMA, INC.	4	S-Sale	--D	2563.0000	77049.0000	1	0001106773	Common
A	2007-12-05		SCIELE PHARMA, INC.	4	A-Award	--D	32000.0000	79612.0000	1	0001106773	Common
D	2007-10-10		SCIELE PHARMA, INC.	4	S-Sale	--D	3500.0000	47612.0000	1	0001106773	Common
D	2007-08-09		SCIELE PHARMA, INC.	4	F-InKind	--D	875.0000	51112.0000	1	0001106773	Common
D	2007-04-25		SCIELE PHARMA, INC.	4	F-InKind	--D	325.0000	51987.0000	1	0001106773	Common
D	2007-02-21		SCIELE PHARMA, INC.	4	S-Sale	--D	1688.0000	52312.0000	1	0001106773	Common
A	2006-12-07		SCIELE PHARMA, INC.	4	A-Award	--D	30000.0000	54000.0000	1	0001106773	Common
A	2006-08-09		SCIELE PHARMA, INC.	4	A-Award	--D	10000.0000	24000.0000	1	0001106773	Common
-	-		Insys Therapeutics, Inc.	3	-	--D			3	0001516479	Stock Option (Right to Buy)
-	-		Insys Therapeutics, Inc.	3	-	--D			2	0001516479	Stock Option (Right to Buy)
-	-		Insys Therapeutics, Inc.	3	-	--D			1	0001516479	Stock Option (Right to Buy)
-	-		FIRST HORIZON PHARMACEUTICAL CORP	3	-	--D		14000.0000	1	0001106773	Common
-	-		REPROS THERAPEUTICS INC.	3	-	---			1	-	-

http://www.sec.gov/cgi-bin/own-disp

---